Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations37
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1227
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing26
Assessing patient understanding of pharmacogenomic test results: a qualitative study24
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting23
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans22
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review19
Patient comprehension of preemptive pharmacogenomic results17
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization16
Genetics and response to treatment with metformin for type 2 diabetes15
Pharmacogenetics of Sulfonylurea-Induced Hypoglycemia in Type 2 Diabetes Patients: the SUCLINGEN Study13
Rapid point of care testing: the next frontier in pharmacogenomics12
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications12
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report12
2.355278968811